MedTrace Logo

Azithromycin Combination Therapy for the Treatment of Uncomplicated Falciparum Malaria in Bangladesh

NCT00356005 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 228

Last updated 2012-11-01

No results posted yet for this study

Summary

The purpose of this study is to investigate the efficacy of azithromycin combination therapy with artesunate for the treatment of uncomplicated falciparum malaria in Bangladesh.

Conditions

  • Uncomplicated Falciparum Malaria

Interventions

DRUG

azithromycin plus artesunate

DRUG

Artesunate

Sponsors & Collaborators

  • International Centre for Diarrhoeal Disease Research, Bangladesh

    collaborator OTHER

  • Armed Forces Research Institute of Medical Sciences, Thailand

    collaborator OTHER_GOV

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Rashidul Haque, MBBS,PhD · International Centre for Diarrhoeal Disease Research, Bangladesh

  • Harald Noedl, MD, MCTM,PhD · Medical University of Vienna

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-08-31
Primary Completion
2007-08-31

Countries

  • Bangladesh

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00356005 on ClinicalTrials.gov